Close

Analyst Ratings for Genmab A/S (GMAB)

GMAB Rating Summary

GMAB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on GMAB
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $45.50 (+58.5%) * Over Last 12-Mos
Rating Score: 2.5 / 10   Percentile Rank: 20%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/23/2024 BMO Capital Etzer Darout Upgrade Outperform
(Market Perform)
48.00
(46.00)
29.11
(28.70)
-1.41% Details
10/18/2023 Exane BNP Paribas Victor Floch New Coverage Underperform
(N/A)
N/A
(N/A)
31.92
(28.70)
-10.09% Details